# Beyond Algorithmic Transparency: Clinicians' Priorities for Explainability in AI-Driven Closed-Loop Neurotechnology

> Clinicians want practical explainability: safe limits, patient benefit, data fit, not model internals. Study maps UI needs, guardrails, uncertainty, and evidence for high-risk use.

- Type: AI news
- Page: https://completeaitraining.com/news/beyond-algorithmic-transparency-clinicians-priorities-for/
- Published: 2025-10-04
- Updated: 2025-10-04
- Author: Jeroen Erne
- Jobs: Science and research
- Reading time: 3 min

### Clinician perspectives on explainability in AI-driven closed-loop neurotechnology

Closed-loop neurotechnology is moving from promise to practice, but explainability remains a sticking point. A new qualitative study of 20 German- and Swiss-based clinicians surfaces a clear takeaway: clinicians don't want a tour of the model's internals-they want clinically meaningful signals that are safe, actionable, and aligned with outcomes.

#### Why this matters

In high-stakes systems that modulate the brain in real time, opacity is more than a technical nuisance. It affects safety, oversight, and trust. Regulatory shifts (e.g., the EU AI Act) now expect "meaningful information" for high-risk AI, making it vital to define what "meaningful" looks like in neurotechnology.

#### Study at a glance

Interviews with 20 clinicians (neurology, neurosurgery, psychiatry) working with closed-loop systems explored what explanations they find useful. Using reflexive thematic analysis, the study mapped priorities across inputs (training data), algorithms, outputs (decisions/actions), and user interfaces.

#### What clinicians actually want explained

- **Inputs (training data):** Representativeness to their patient population; clarity on inclusion of multimodal sources (wearables, video, patient-reported outcomes); evidence of artifact handling; sample size and variability; and when possible, access to source data for independent inspection.
- **Algorithms:** Low interest in architecture details (layers, parameters). High expectation that engineers, manufacturers, and regulators handle deep validation and safety. Transparency at the system level matters more than model internals.
- **Outputs (decisions/actions):** Safety limits and operational logic (how a signal changes stimulation). Hard boundaries on autonomous adjustments. Trust increases when outputs align with clinical reasoning and show real patient benefit in trials, not just technical metrics.

#### Interface expectations

- **Data transparency via visuals:** Descriptive statistics, charts, and symptom-cluster views to judge patient-dataset fit.
- **Grounding in evidence:** Links to peer-reviewed sources that support a given recommendation to help users verify medical rationale.
- **Explainability tools, selectively:** Feature importance, relevance rankings, and counterfactuals for targeted use. Some clinicians still prefer paper-based summaries for complex cases-flexibility is key.
- **Practical intelligibility over full transparency:** Visualization helps, but the goal is safe, confident use-not exposing every model detail.

#### Key risks clinicians flagged

- **Epiphenomena and spurious proxies:** Models can latch onto statistically strong but clinically meaningless signals. Explanations must help distinguish correlation from plausible mechanisms.
- **Dual-layer opacity in neurotech:** Inputs themselves (e.g., LFPs, EEG) are not inherently interpretable to many clinicians, compounding the model's black box.
- **Overhype:** Interest is high, but expectations are tempered. Benefits must be shown in realistic clinical studies, not only in lab settings.

#### Design principles you can act on

- **Prioritize functional intelligibility:** Show how inputs map to outputs and patient-relevant endpoints; avoid deep dives into architecture unless required for safety cases.
- **Build hard guardrails:** Enforce safe operating ranges for autonomous parameter updates; surface these limits in the UI.
- **Adopt hybrid explainability:** Combine feature importance and saliency with case-based examples (similar patient trajectories) and counterfactuals.
- **Lean into multimodal data:** Fuse neural signals with wearables, video, and patient-reported outcomes to improve clinical relevance.
- **Be artifact-aware:** Show preprocessing steps and quality indicators so users know the model learned from signal, not noise.
- **Expose uncertainty:** Provide confidence or reliability scores alongside recommendations.
- **Keep clinicians in the loop:** Enable overrides, audit trails, and clear handoffs between autonomous and clinician-controlled modes.
- **Adaptive interfaces:** Let users drill down from high-level justification to data evidence; support both digital dashboards and printable summaries.
- **Two-way explanations:** Where appropriate, conversational tools can translate technical outputs into clinical language without overpromising.

#### Governance and policy notes

Expectations for high-risk AI include human oversight, safety, and the right to meaningful information. For context, see the EU AI Act's provisions on explanation and oversight: [Article 86](https://artificialintelligenceact.eu/article/86/?ref=completeaitraining.com).

- **Tiered explainability:** Different stakeholders need different views-clinicians (functional clarity), regulators (assurance and accountability), patients (rights-based explanations).
- **Data access incentives:** Balanced frameworks for sharing deidentified datasets can strengthen validation while respecting IP and privacy law.
- **Clinical accountability:** AI-generated parameters must meet the same scrutiny as other clinical interventions.
- **Independent validation and monitoring:** Real-world performance, safety events, and drift should be continuously evaluated.

#### Limitations and scope

The sample was limited to 20 German-speaking clinicians, with uneven gender participation and varied AI literacy. Findings are qualitative and not statistically generalizable. This work identifies end-user requirements; it is not a proof-of-concept for specific AI or XAI methods.

#### What's next

- Translate these requirements into testable metrics, benchmarks, and interface patterns.
- Run co-designed pilots with clinicians to validate usability and safety under real constraints.
- Include patient perspectives, especially for autonomous adjustments that affect mental or physical integrity.
- Leverage new implantable devices for longitudinal, real-world datasets and prospective trials.

Deidentified quotes supporting the themes are available on Zenodo: [https://doi.org/10.5281/zenodo.16528872](https://doi.org/10.5281/zenodo.16528872?ref=completeaitraining.com).

---

This is the Markdown form of https://completeaitraining.com/news/beyond-algorithmic-transparency-clinicians-priorities-for/. The whole site is mapped at https://completeaitraining.com/llms.txt.
